Xilio Therapeutics' Series B Round

Xilio Therapeutics raised a round of funding on March 02, 2020.

Xilio Therapeutics is a privately-held biopharmaceutical company focused on developing highly-potent, targeted immuno-oncology therapeutics. The company's Aklusion platform technology allows biologics…

Articles about Xilio Therapeutics' Series B Round: